Tone mix
Week by week 52 weeks
Share of Candel Therapeutics, Inc. Common Stock's 140 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Jul 20, 2026 · tone -100Candel Therapeutics (NASDAQ:CADL) Downgraded to Sell Rating by Wall Street Zen-99
- Week of Dec 15, 2025 · tone +100Candel Therapeutics, Inc. (NASDAQ:CADL) Receives Average Recommendation of "Moderate Buy" from Analysts+88
- Week of Sep 28, 2026 · tone +99Candel Therapeutics Announces New Data Showing Sustained Immune Remodeling More Than Two Years After Aglatimagene Besadenovec Treatment in Localized Prostate Cancer at ASTRO 2026+87
- Week of Sep 29, 2025 · tone +100Candel Therapeutics' CAN-2409 delivers durable benefit in positive phase 3 prostate cancer trial+80
- Week of Jul 6, 2026 · tone +97Candel Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)+75
- Week of May 19, 2025 · tone +100Candel Therapeutics Presents Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025+72
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Candel Therapeutics, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 3 | 0 |
| Last 30 sessions | 5 | +20 |
| Last 90 sessions | 30 | +6 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Tuesday, October 27, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.manilatimes.net · 1 outletCandel Therapeutics to Present at November Investor ConferencesNeutral
- www.themarketsdaily.com · 1 outletRecent Analysts' Ratings Changes for Candel Therapeutics (CADL)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Candel Therapeutics to Present at November Investor Conferences | www.manilatimes.net | 1 | Neutral |
| Recent Analysts' Ratings Changes for Candel Therapeutics (CADL) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 22, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletCandel Therapeutics Appoints Maria Ostrovsky as General CounselNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Candel Therapeutics Appoints Maria Ostrovsky as General Counsel | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 5, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletCandel Therapeutics to Present at the SITC 2026 Annual MeetingNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Candel Therapeutics to Present at the SITC 2026 Annual Meeting | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, September 30, 2026
1 headline, average tone +99: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletCandel Therapeutics Announces New Data Showing Sustained Immune Remodeling More Than Two Years After Aglatimagene Besadenovec Treatment in Localized Prostate Cancer at ASTRO 2026Positive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Candel Therapeutics Announces New Data Showing Sustained Immune Remodeling More Than Two Years After Aglatimagene Besadenovec Treatment in Localized Prostate Cancer at ASTRO 2026 | www.manilatimes.net | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, September 10, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.finanznachrichten.de · 1 outletCandel Therapeutics Appoints Martine Zimmermann, PharmD, to its Board of DirectorsNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Candel Therapeutics Appoints Martine Zimmermann, PharmD, to its Board of Directors | www.finanznachrichten.de | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Candel Therapeutics, Inc. Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.